Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 112, Issue 6, 2248-2260, September 15, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)
Blood Mead et al. 112: 2248

Supplemental materials for: Mead et al

Participating Clinicians:

The participating clinicians were as follows: Belfast City Hospital, Dr RJG Cuthbert, Dr P Kettle, Dr MF McMullin, Bristol Oncology Centre, Dr RS Evely, Dr C Price, Cheltenham General Hospital, Dr R Lush, Christchurch Hospital, Dr R Spearing, Christie Hospital, Dr J Radford, City Hospital Nottingham, Dr A P Haynes, Derriford Hospital, Dr M Hamon, Doncaster Royal Infirmary, Dr J Joseph, Geelong Hospital, Dr P Campbell, Good Hope Hospital, Dr MS Hamilton, Dr M Lumley, Heartlands Hospital, Dr DW Milligan, Dr G Pratt, Hillingdon Hospital, Dr R Jan-Mohammed, Hull Royal Infirmary, Dr R Patmore, Dr ML Shields, James Cook University Hospital, Dr D Plews, James Paget Hospital, Dr J Braithwaite, Dr S Sadullah, Kettering General Hospital, Dr M Lyttelton, King's College Hospital, Dr A Pagliuca, Leeds General Infirmary, Dr JA Child, Prof G Morgan, Dr G Smith, Monklands District General Hospital, Dr J Murphy, Dr WH Watson, Mount Vernon Hospital, Dr K Ardshna, New Cross Hospital, Dr A MacWhannell, Peter MacCallum Cancer Institute, A/Professor M Prince, Dr J Seymour, Dr M Wolf, Pinderfields General Hospital, Dr P Hillmen, Royal Cornwall Hospital, Dr R Noble, Royal Devon & Exeter Hospital, Dr MV Joyner, Dr R Lee, Dr C Rudin, Royal Free Hospital, Dr P Kottaridis, Dr M Potter, Royal Hallamshire Hospital, Dr J Wright, Aberdeen Royal Infirmary, Dr D Culligan, Professor J A L Yin, Royal Marsden Hospital, Professor D Cunningham, Royal Melbourne Hospital, Assistant Professor A Grigg, Royal United Hosptial, Dr C Knechtli, Royal Victoria Infirmary, Dr G Jackson, Dr A Lennard, Prof S Proctor, Russells Hall Hospital, Dr P Harrison, Sandwell General Hospital, Dr PJ Stableforth, Singleton Hospital, Dr S Al-Ismail, Dr A Benton, Southampton General Hospital, Dr GM Mead, St James's University Hospital, Dr R Johnson, Dr B A McVerry, St. Bartholomew's Hospital, Prof A Lister, Staffordshire General Hospital, Dr TAS Amos, P Revell, Taunton & Somerset Hospital, Dr S Bolam, Dr SAN Johnson, The John Radcliffe, Dr C Hatton, University College Hospital, Professor A Goldstone, Prof DC Linch, Walsgrave Hospital, Dr B D Harrison, Warsaw, MSCM Cancer Center, Dr. K Domanska-Czyz, Dr J Romejko-Jarosinska, Dr JA Walewski, Western General Hospital, Dr J Davies, Dr MJ Mackie, Western Infirmary, Dr EJ Fitzsimons, Dr NP Lucie, Weston Park Infirmary, Professor BW Hancock, Wexham Park Hospital, Dr N Bienz, Wycombe General Hospital, Dr R Aitchison, Dr S Kelly.

The Independent Data Monitoring Committee members were Professor H Scarffe (chair), Professor R Prescott and Dr R Glynne-Jones





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020